Diarrhea drug trial halted early: what we know
NCT ID NCT04486326
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether crofelemer, a drug that reduces fluid secretion in the gut, could improve stool consistency in adults with functional diarrhea. The trial was terminated early after enrolling only 17 participants. The main goal was to measure stool firmness after 4 weeks of treatment compared to a placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIARRHEA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a postbiotic soothe diarrhea in vulnerable kids?
- School health rooms and trained teachers: a new hope for Zambia's children?
- New Stool-Based care pathway aims to tame diarrhea in ICU patients on tube feeding
- Gut bacteria may hold key to chemo side effects
- Weight-Loss drugs may cause hidden anal issues, new study warns
- Gut check: 4,000-Person study links diet, genes, and stomach troubles